Krystal Biotech, Inc. (KRYS): Weighted Average Diluted Shares
29.95M
Year ended 2025-12-31
+5.5%
3-year compound annual growth
+9.8%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 29.95M | +0.7% | 2026-02-17, From 2025-01-01 |
| 2024-12-31 | 29.74M | +7.2% | 2026-02-17, From 2024-01-01 |
| 2023-12-31 | 27.75M | +8.9% | 2026-02-17, From 2023-01-01 |
| 2022-12-31 | 25.49M | +14.8% | 2025-02-19, From 2022-01-01 |
| 2021-12-31 | 22.20M | +18.1% | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | 18.79M | n/a | 2023-02-27, From 2020-01-01 |